I'm new here, and positioned at 1c, i still dont like that existing holders had to get shafted.
The tech is an essential new medical product as i see it. Panc cancer one of those with such high mortality, that this device has to find a way to JV to carry it over the line, for the benefit of all. The question is, what price would be fair to the return on investors ? And surely, trial patient recruitment would be no issue ? I mean, death is otherwise knocking....so i would have thought that patients would be trying to knock the door in, or travelling to a country where it is available ???
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
0.015(1.48%) |
Mkt cap ! $14.65M | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.05 | 95.0¢ | $109.7K | 112.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23906 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 2292 | 2 |
View Market Depth
| Last trade - 15.57pm 19/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |